CorMedix (CRMD) Short-term Investments (2015 - 2025)

CorMedix has reported Short-term Investments for 10 years, with the latest figure at $10.4 million in Q4 2025.

• Quarterly Short-term Investments fell 6.1% year-over-year to $10.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.4 million (down 6.1% YoY) and the FY2025 annual result came in at $10.4 million, down 6.1% from the prior year.
• Short-term Investments grew to $10.4 million in Q4 2025 per CRMD's latest filing, from $8.1 million in the prior quarter.
• Over five years, Short-term Investments peaked at $33.3 million in Q3 2023 and troughed at $121214.0 in Q2 2022.
• A 5-year average of $13.0 million and a median of $10.9 million in 2024 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2021 and 2022: Short-term Investments surged 60645.02% in 2021, then tumbled 98.98% in 2022.
• Over 5 years, Short-term Investments stood at $12.1 million in 2021, then sank by 98.98% to $124102.0 in 2022, then soared by 25997.99% to $32.4 million in 2023, then plunged by 65.92% to $11.0 million in 2024, then slipped by 6.1% to $10.4 million in 2025.
• According to Business Quant data, Short-term Investments over the past three periods registered $10.4 million, $8.1 million, and $31.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.